Short Sellers Retract Bets in Major Social Media Stocks
The August 31 short interest data have been compared with the previous report. Short interest was down across the board in these selected social media stocks.
All Work
Chris Lange
Cybersecurity Short Sellers Start to Take Money off the Table
The August 31 short interest data have been compared with the previous figures, and short interest moves for most of the selected cybersecurity stocks were down.
Short Sellers Grow More Selective on Major Semiconductors
The August 31 short interest data have been compared with the previous report. Short interest was mixed in these selected semiconductor stocks.
Major Pharma Continues to See Significant Drop in Short Interest
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest has significantly decreased.
Short Sellers Decrease Bets in Major Oil
The August 31 short interest data have been compared with the previous figures, and short interest for the selected oil stocks was mixed but largely down.
Short Sellers Run for Cover From Major Biotechs
The August 31 short interest data have been compared with the previous report, and short interest decreased for most of these selected biotech stocks.
Eagle Materials Moves to Acquire CEMEX Ohio Operation
Eagle Materials announced early Monday that it had entered into a definitive agreement to acquire Cemex’s Fairborn Ohio cement plant, and related assets.
Polaris Slides on Guidance Update
Polaris Industries Inc. (NYSE: PII) slid early on Monday following an update to its full-year guidance. The company expects that its 2016 earnings per share (EPS) to be in the range of $3.30 to $3.80,…
Apptio Announces Potential Price Range for IPO
Apptio expects to price 6 million shares between $13 and $15 a piece in an initial public offering valued up to more than $103 million.
Valvoline Gears Up for IPO
Valvoline expects to price 30 million shares at up to $23 per share in an initial public offering valued up to more than $793 million.
Why Horizon Pharma Is Not Overpaying for Raptor Pharma
If we look at what Horizon is paying, it doesn’t necessarily add up, using the numbers from this year, but if we look at more data the picture becomes clearer.
4 Key BioPharma Movers in the Past Week
Some biotech companies made impressive runs over the course of this past week. These select few stood out from the rest.
What Analysts Are Saying After the Apple iPhone Debut
Practically everyone had an opinion on the new iPhone 7, as well as where Apple and the iPhone stand to go from here.
What to Expect From Oracle Earnings This Week
Oracle is expected to release its fiscal first-quarter financial results on this coming Thursday.
Why Analysts Are Chasing Finisar Targets Up So Much
Finisar kicked off its fiscal year with a solid beat in the first quarter, and it is looking to continue to beat in the second.
5 Companies That Destroyed Shareholders Last Week
There are a fair number of questions for what the markets hold after this summer, but a somewhat negative analyst sentiment surrounds Friday's move lower.
Restoration Hardware Earnings Overcome Near-Term Weakness
Restoration Hardware admitted to short-term weakness in the future that some would think should send the shares lower. However this was not the case.
Why Lexicon Pharma Is Soaring
Lexicon Pharmaceuticals rallied Friday on late-stage results from a pivotal Phase 3 clinical trial of a type 1 diabetes treatment.
Why a Kroger Earnings Beat Is Not Enough for Investors
Kroger reported mixed fiscal second-quarter financial results and lowered its guidance before the markets opened Friday.
Why Repros Is Rising
Shares of Repros Therapeutics climbed in Thursday’s session after the company announced results from its mid-stage study for women with moderate to severe confirmed endometriosis.